ADVA
10.9.2020 09:02:04 CEST | Business Wire | Press release
ADVA (FSE: ADV) today announced that Alsard Fiber is utilizing its FSP 3000 OLS technology to provide extremely resilient, high-capacity services across Iraq. The solution enables the country’s fastest-growing IP service wholesaler to improve quality, avoid downtime and deliver on high-value SLAs for its ISP, telecom, government and business customers. Protected by ADVA’s multi-degree ROADMs, which automatically reroute traffic in the case of fiber breaks, the new infrastructure is Iraq’s only network with end-to-end redundancy for maximum availability. What’s more, Alsard Fiber’s infrastructure is assured by ADVA ALM fiber monitoring technology, empowering it to remotely identify areas of degradation and rapidly locate faults, boosting reliability and significantly reducing cost.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20200910005037/en/
“What we needed from this deployment was high capacity, resilience and the ability to guarantee our stringent SLAs. ADVA’s technology gives us a network that delivers on all counts. Now we can support our huge customer base with a redundant, monitored and robustly protected fiber backbone able to provide fast and reliable services and ready to withstand the most difficult environments,” said Firya Mohammad Ali, CEO, Alsard Fiber. “We’ve invested heavily in our fiber plant. Our network stretches thousands of kilometers across the country and this new solution helps us realize the full value of our assets. It enables us to boost efficiency and reliability and ensure the stability that our customers demand.”
Built on the ADVA FSP 3000, Alsard Fiber’s new network is designed for efficiency, ease of use and the highest levels of robustness. The fully redundant infrastructure leverages ADVA’s QuadFlex™ line cards and flexible ROADM technology so that traffic can be easily rerouted and new services remotely activated. With real-time fiber monitoring from ADVA’s ALM system , the solution saves Alsard Fiber time and money as faults can be resolved quickly with fewer truck rolls. Able to support a wide variety of data rates from 10Gbit/s to 40Gbit/s to 100Gbit/s, the modular solution also gives Alsard Fiber the flexibility to expand its network cost-effectively and without limits.
“Alsard Fiber is committed to providing its customers with highly reliable services and that requires extremely high levels of network survivability. Now, with our QuadFlex™ transponders and ultra-flexible ROADM layer, traffic can be instantly redirected in the event of any impairments. What’s more, with full network visibility, Alsard Fiber’s maintenance teams can take efficient, targeted action to head off faults before they become service issues,” commented Hartmut Müller-Leitloff, SVP, sales, EMEA, ADVA. “Alsard Fiber now has the tools to provide robust and reliable services throughout Iraq. With our technology and support, it will continue to deliver on the promises of strict SLAs and ensure vital connectivity where it’s most needed.”
About ADVA
ADVA is a company founded on innovation and focused on helping our customers succeed. Our technology forms the building blocks of a shared digital future and empowers networks across the globe. We’re continually developing breakthrough hardware and software that leads the networking industry and creates new business opportunities. It’s these open connectivity solutions that enable our customers to deliver the cloud and mobile services that are vital to today’s society and for imagining new tomorrows. Together, we’re building a truly connected and sustainable future. For more information on how we can help you, please visit us at www.adva.com .
Published by:
ADVA Optical Networking SE, Munich, Germany
View source version on businesswire.com: https://www.businesswire.com/news/home/20200910005037/en/
Social Media:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Barilla Opens Global Call for Startups Through Good Food Makers 202625.5.2026 11:47:00 CEST | Press release
The program has involved over 1,100 startups across 50+ countries, delivering 26 pilot projects. Barilla Group has opened applications for the 2026 edition of Good Food Makers, its global open innovation program designed to co-develop and test new innovative solutions with startups and innovators inside real industrial environments. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260521973445/en/ Since its launch in 2019, the program has involved more than 1,100 startups from over 50 countries, leading to 26 pilot projects, with over 20 projects currently active thanks to the solutions developed by the program’s alumni. This highlights the program’s role as a concrete platform for industrial scalable innovation. The 2026 edition comes at a pivotal moment for the company, following the launch of BITE (Barilla Innovation & Technology Experience), the new innovation center dedicated to developing the next generation of food prod
JEOL: Sales Launch of the Laser SEM System “LazEdge”25.5.2026 10:16:00 CEST | Press release
JEOL Ltd. (President & CEO: Izumi Oi) has developed the “LazEdge”, an SEM system equipped with a laser processing system, and begins sales on May 25, 2026. Cross-section preparation instruments such as the focused ion beam system (FIB system), are widely used in science and technology fields across research institutes, universities, and industries. In recent years, demand is increasing for a system that can process large-areas at a high speed, while achieving high-quality of the processed surface. “LazEdge” is an instrument integrating JEOL’s SEM with the laser technology proprietary of Hamamatsu Photonics K.K., and enables laser processing inside the specimen chamber of the electron microscope. This system enables high-quality cross-section specimens produced through high-speed, large-area processing to be transferred seamlessly to subsequent analyses, such as SEM observation, elemental analysis, and crystal orientation analysis, without exposure to the external environment. As a resu
TFG-001, A Novel 3D Neural Microtissue Cell Therapy, Demonstrates Superior Functionality and Reinnervation for Parkinson’s Disease25.5.2026 08:00:00 CEST | Press release
TreeFrog Therapeutics, a regenerative medicine biotech company developing next-generation cell therapies, today announced that it will present new preclinical data on TFG-001 at the 7th World Parkinson’s Conference. TFG-001, a 3D neural microtissue cell therapy, demonstrated rapid dopamine release and extensive graft-derived reinnervation across multiple advanced translational Parkinson’s disease models—supporting its potential as a best-in-class candidate. The critical need for reinnervation in Parkinson's disease In Parkinson's disease, an estimated 60–80% of dopaminergic neurons are already lost before motor symptoms even appear. The nigrostriatal pathway degenerates, destroying the essential wiring that connects dopamine-producing neurons to movement control. While chemical dopamine replacements (like levodopa) can manage symptoms, they cannot restore the spatial precision, feedback loops, or dynamic regulation of a healthy brain network. To achieve true functional restoration, it
Galderma Receives U.S. FDA Approval for Differin® Epiduo® Acne Gel Prescription-to-OTC Switch22.5.2026 18:25:00 CEST | Press release
A unique Prescription-to-OTC switch in acne care, this approval expands access to a dermatologist-trusted, prescription-strength treatment for millions of acne sufferers ages 12 years and older Backed by more than 15 years of real-world dermatologist use and a robust clinical research program, this milestone demonstrates the depth of science behind the Differin® and Epiduo® heritage Adapalene plus benzoyl peroxide (0.1/2.5%) was the first FDA-approved, stable, fixed- dose prescription acne treatment to combine of benzoyl peroxide with a retinoid, and is now available over-the-counter The formulation is engineered to target multiple causes of acne more effectively than either of its individual active ingredients alone Galderma (SIX: GALD), the pure-play dermatology category leader, today announced that the United States (U.S.) Food and Drug Administration (FDA) has approved Differin® Epiduo® Acne Gel (Adapalene 0.1% and Benzoyl Peroxide 2.5% Acne Treatment) for over-the-counter (OTC) us
Avanzanite Bioscience’s Partner Agios Announces PYRUKYND® (mitapivat) Approval in the European Union for Adults with Thalassaemia22.5.2026 16:18:00 CEST | Press release
Avanzanite will commercialise and distribute PYRUKYND in Europe under its exclusive agreement with Agios Avanzanite is committed to collaborating with local authorities in the EU to enable access to PYRUKYND for adult patients with thalassaemia Avanzanite Bioscience B.V., a rapidly growing commercial-stage European specialty pharmaceutical company focused on rare diseases, today reported that its partner, Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a commercial-stage biopharmaceutical company headquartered in Cambridge, Massachusetts focused on delivering innovative medicines for patients with rare diseases, announced that the European Commission has granted marketing authorisation for PYRUKYND® (mitapivat), an oral pyruvate kinase (PK) activator, in adults for the treatment of anaemia associated with transfusion-dependent and non-transfusion-dependent alpha- or beta-thalassaemia, with an orphan medicinal product designation. This press release features multimedia. View the full releas
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom